As one of the most exciting yet controversial segments of the orthopedics market, the U.S. spinal implant market has seen rapid growth and increasing market size. Now, many manufacturers consider spinal implants a separate business division from traditional orthopedics. Following the decrease in 2020 caused by the COVID-19 pandemic, the U.S. spinal implant, and vertebral
2020 was an unusual year mainly because of the global COVID-19 pandemic, which caused a 6% decrease in the U.S. minimally invasive spinal implant market from 2019 to 2020. The market impact caused by COVID-19 did differ by segment. Some segments felt the heat and decreased accordingly, whereas others experienced high growth despite the pandemic.
Overview In the United States alone, there are over 50 interbody device companies all competing for market share. But who really are the top competitors within this growing market and how are they succeeding above the rest? Despite COVID-19 headwinds, the interbody device market is prosperous as many companies have grown significantly and are experiencing
Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody high-speed drills with the Robotic Guidance System. Even in the midst of the COVID19 pandemic the company has received the clearance earlier than anticipated. This system now integrates the surgical planning software with robotic guidance. Spinal instruments
October 16th is the official World Spine Day, organized and coordinated by the World Federation of Chiropractors. This year’s theme is Back On Track, celebrating people being able to reactivate and revitalize their bodies by getting out and focusing on effective spine care. World Spine Day is celebrated to raise awareness around the prevention and
Vivex is a company based out of Atlanta, Georgia, that specializes in regenerative medicine. Vivex has developed the VIA Disc, an innovative injectable treatment for degenerative disc disease. The first major clinical study regarding this treatment was conducted recently, with promising results. Lower back pain is the leading cause of work disability in the world
The FDA has granted 510(k) clearance for the Osteo3 ZP Putty from Sirakoss Ltd. Sirakoss is based out of Aberdeen, Scotland, and originated from research conducted out of the University of Aberdeen. Sirakoss produces nanosynthetic bone regeneration products, providing an alternative to other devices used in spine and trauma bone grafts. Products such as these
From the onset of COVID-19, changes were made to various facets of healthcare systems, including the Spine Surgery industry. Many of these changes were adopted in a reactionary manner, in order to protect those at risk. However, it has become evident that some of these changes bear issues that must be addressed to ensure optimal
Augmedics, a company based out of Chicago, gained FDA approval for the sale of its XVision Spine System in the U.S. in December 2019. Now, this technology has been used for its first spine surgery in the U.S. Using the patient’s CT scan data, the XVision Spine System provides a 3-dimensional visualization of the patient’s
